HEPATIC STEATOSIS
Clinical trials for HEPATIC STEATOSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC STEATOSIS trials appear
Sign up with your email to follow new studies for HEPATIC STEATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can eating on a schedule and working out beat fatty liver disease?
Disease control CompletedThis study tested whether combining time-restricted eating (eating within a specific daily window) with supervised exercise is more effective at reducing harmful liver fat and improving heart health than doing either one alone. It involved 187 adults with obesity over 12 weeks. R…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Universidad de Granada • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Teen Weight-Loss surgery study reveals liver changes
Knowledge-focused CompletedThis research study aimed to understand how weight-loss surgery affects liver fat and metabolism in obese teenagers. Researchers followed 20 adolescents aged 13-20 before and one year after their surgery, measuring liver fat, insulin sensitivity, and metabolic markers. The study …
Matched conditions: HEPATIC STEATOSIS
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
First humans test new fatty liver injection
Knowledge-focused CompletedThis early-stage study tested the safety of a single injection of a new experimental drug called NNC0581-0001. It involved 48 healthy adults and people with fatty liver disease to see how their bodies handled the drug and to check for side effects. The main goal was to gather ini…
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Could hormone therapy help Women's livers?
Knowledge-focused CompletedThis study looked at whether menopausal hormone therapy (MHT) affects liver health in postmenopausal women. It followed 44 women for six months, with half receiving MHT and half not. Researchers measured liver fat and function to see if the therapy led to any positive changes.
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Ipek B. Ozcivit Erkan, MD • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:10 UTC